Pasithea Therapeutics Statistics
Total Valuation
KTTA has a market cap or net worth of $25.31 million. The enterprise value is $21.19 million.
Important Dates
The last earnings date was Thursday, November 13, 2025, after market close.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
KTTA has 22.40 million shares outstanding. The number of shares has increased by 298.39% in one year.
| Current Share Class | 22.40M |
| Shares Outstanding | 22.40M |
| Shares Change (YoY) | +298.39% |
| Shares Change (QoQ) | +31.95% |
| Owned by Insiders (%) | 1.66% |
| Owned by Institutions (%) | 4.99% |
| Float | 87.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.69 |
| P/TBV Ratio | 6.17 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.02
| Current Ratio | 4.02 |
| Quick Ratio | 2.99 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -89.90% and return on invested capital (ROIC) is -57.72%.
| Return on Equity (ROE) | -89.90% |
| Return on Assets (ROA) | -53.70% |
| Return on Invested Capital (ROIC) | -57.72% |
| Return on Capital Employed (ROCE) | -113.12% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.37M |
| Employee Count | 4 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.17% in the last 52 weeks. The beta is 0.21, so KTTA's price volatility has been lower than the market average.
| Beta (5Y) | 0.21 |
| 52-Week Price Change | -61.17% |
| 50-Day Moving Average | 0.78 |
| 200-Day Moving Average | 0.92 |
| Relative Strength Index (RSI) | 60.56 |
| Average Volume (20 Days) | 21,473,730 |
Short Selling Information
The latest short interest is 23,343, so 0.10% of the outstanding shares have been sold short.
| Short Interest | 23,343 |
| Short Previous Month | 38,606 |
| Short % of Shares Out | 0.10% |
| Short % of Float | 0.03% |
| Short Ratio (days to cover) | 0.24 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -13.86M |
| Pretax Income | -13.49M |
| Net Income | -13.49M |
| EBITDA | -13.19M |
| EBIT | -13.86M |
| Earnings Per Share (EPS) | -$3.25 |
Full Income StatementBalance Sheet
The company has $4.12 million in cash and n/a in debt, giving a net cash position of $4.12 million or $0.18 per share.
| Cash & Cash Equivalents | 4.12M |
| Total Debt | n/a |
| Net Cash | 4.12M |
| Net Cash Per Share | $0.18 |
| Equity (Book Value) | 12.21M |
| Book Value Per Share | 1.64 |
| Working Capital | 4.15M |
Full Balance SheetCash Flow
| Operating Cash Flow | -12.26M |
| Capital Expenditures | n/a |
| Free Cash Flow | -12.26M |
| FCF Per Share | -$0.55 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |